Evaluation of Ranibizumab and PDT for patients with pathologic myopia and macular CNV
AIM: To evaluate the efficacy of anti- vascular endothelial growth factor(VEGF)and photodynamic therapy(PDT)on pathological myopia(PM)combined with choroidal neovascularization(CNV). <p>METHODS: Forty-three patients(45 eyes)diagnosed by fundus fluorescein angiography(FFA), indocyanine green an...
Main Authors: | Jing Yan, Chong Xu, Li Yan, Li-Ping Hu, Yan Zhao, Gui-Lan Luo, Jian-Hua Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2018-02-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://www.ijo.cn/cn_publish/2018/3/201803022.pdf |
Similar Items
-
Application of ETDRS chart and mfERG in assessing pathologic myopia combined with macular CNV after treatment
by: Jing Yan, et al.
Published: (2018-07-01) -
Therapeutic effect of photodynamic therapy and intravitreal injection with ranibizumab for choroidal neovascularization of pathologic myopia
by: Cong Zhang, et al.
Published: (2014-07-01) -
Observation of the macular thickness after the treatment of choroidal neovascularization with pathological myopia
by: Li Yan, et al.
Published: (2018-02-01) -
Two years follow-up outcome of verteporfin therapy for subfoveal choroidal neovascularization in pathologic myopia in Indian eyes
by: Hussain Nazimul, et al.
Published: (2008-01-01) -
Long-term outcomes of combination photodynamic therapy with ranibizumab or bevacizumab for treatment of wet age-related macular degeneration
by: Ekta Rishi, et al.
Published: (2016-01-01)